Literature DB >> 10518728

Inhibition of IMP-1 metallo-beta-lactamase and sensitization of IMP-1-producing bacteria by thioester derivatives.

G G Hammond1, J L Huber, M L Greenlee, J B Laub, K Young, L L Silver, J M Balkovec, K D Pryor, J K Wu, B Leiting, D L Pompliano, J H Toney.   

Abstract

IMP-1 metallo-beta-lactamase is a transferable carbapenem-hydrolyzing enzyme found in some clinical isolates of Pseudomonas aeruginosa, Serratia marcescens and Klebsiella pneumoniae. Bacteria that express IMP-1 show significantly reduced sensitivity to carbapenems and other beta-lactam antibiotics. A series of thioester derivatives has been shown to competitively inhibit purified IMP-1. As substrates for IMP-1, the thioesters yielded thiol hydrolysis products which themselves were reversible competitive inhibitors. The thioesters also increased sensitivity to the carbapenem L-742,728 in an IMP-1-producing laboratory stain of Escherichia coli, but will need further modification to improve their activity in less permeable organisms such as Pseudomonas and Serratia. Nonetheless, the thioester IMP-1 inhibitors offer an encouraging start to overcoming metallo-beta-lactamase-mediated resistance in bacteria.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10518728     DOI: 10.1111/j.1574-6968.1999.tb08740.x

Source DB:  PubMed          Journal:  FEMS Microbiol Lett        ISSN: 0378-1097            Impact factor:   2.742


  13 in total

1.  Inhibition of beta-lactamase II of Bacillus cereus by penamaldic derivatives of penicillins.

Authors:  Pilar Gutiérrez Navarro; Bartolomé Quintero Osso; Raquel García Ortiz; Pedro J Martínez De Las Parras; María I Martínez Puentedura; M Carmen Cabeza González
Journal:  Antimicrob Agents Chemother       Date:  2004-03       Impact factor: 5.191

2.  Impact of remote mutations on metallo-beta-lactamase substrate specificity: implications for the evolution of antibiotic resistance.

Authors:  Peter Oelschlaeger; Stephen L Mayo; Juergen Pleiss
Journal:  Protein Sci       Date:  2005-03       Impact factor: 6.725

3.  Metallo-beta-lactamase or extended-spectrum beta-lactamase: a wolf in sheep's clothing.

Authors:  Björn A Espedido; Lee C Thomas; Jonathan R Iredell
Journal:  J Clin Microbiol       Date:  2007-04-04       Impact factor: 5.948

Review 4.  Fragment-based inhibitor discovery against β-lactamase.

Authors:  Derek A Nichols; Adam R Renslo; Yu Chen
Journal:  Future Med Chem       Date:  2014-03       Impact factor: 3.808

Review 5.  Metallo-β-Lactamases: Structure, Function, Epidemiology, Treatment Options, and the Development Pipeline.

Authors:  Sara E Boyd; David M Livermore; David C Hooper; William W Hope
Journal:  Antimicrob Agents Chemother       Date:  2020-09-21       Impact factor: 5.191

Review 6.  Metallo-beta-lactamases: the quiet before the storm?

Authors:  Timothy R Walsh; Mark A Toleman; Laurent Poirel; Patrice Nordmann
Journal:  Clin Microbiol Rev       Date:  2005-04       Impact factor: 26.132

Review 7.  Antibacterials from the sea.

Authors:  Chambers C Hughes; William Fenical
Journal:  Chemistry       Date:  2010-11-08       Impact factor: 5.236

8.  N-arylsulfonyl hydrazones as inhibitors of IMP-1 metallo-beta-lactamase.

Authors:  Stefan Siemann; Darryl P Evanoff; Laura Marrone; Anthony J Clarke; Thammaiah Viswanatha; Gary I Dmitrienko
Journal:  Antimicrob Agents Chemother       Date:  2002-08       Impact factor: 5.191

Review 9.  Diversity and Proliferation of Metallo-β-Lactamases: a Clarion Call for Clinically Effective Metallo-β-Lactamase Inhibitors.

Authors:  Anou M Somboro; John Osei Sekyere; Daniel G Amoako; Sabiha Y Essack; Linda A Bester
Journal:  Appl Environ Microbiol       Date:  2018-08-31       Impact factor: 4.792

10.  Inhibitor discovery of full-length New Delhi metallo-β-lactamase-1 (NDM-1).

Authors:  Bingzheng Shen; Yan Yu; Hui Chen; Xin Cao; Xingzhen Lao; Yongliang Fang; Yun Shi; Jiao Chen; Heng Zheng
Journal:  PLoS One       Date:  2013-05-13       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.